References
- Singh M, Das RR. Clinical potential of zinc in prophylaxis of the common cold. Expert Rev. Respir. Med. 5(3), 301–303 (2011).
- Eby GA, Davis DR, Halcomb WW. Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study. Antimicrob. Agents Chemother. 25(1), 20–24 (1984).
- Eby GA. Chapter 3A, Mouth–nose electric circuit. In: Handbook for Curing the Common Cold. George Eby Research, Austin, TX, USA, 24 (1994).
- Rosch PJ. Afterward. In: Exploring BCEC Systems (Biologically Closed Electric Circuits). Nordenstrom BEW (Ed.). Nordic Medical Publications, Uppsala, Sweden, 106 (1998).
- Nordenström BE. Biologically Closed Electric Circuits. Clinical, Experimental and Theoretical Evidence for an Additional Circulatory System. Nordic Medical Publications, Stockholm, Sweden (1983).
- Sceusa NA, Ehrlich PM. Proof of electro-osmotic drug delivery: a prejudiced clinical trial, delivering from mouth to nose. Drug Deliv Technol. 8(9), 50–59 (2008).
- Sceusa NA. The Teorell–Meyer dosage forms: is electro-osmotic drug delivery possible? Deliv. Technol. 3(2), 40–47 (2003).
- Korant BD, Butterworth BE. Inhibition by zinc of rhinovirus protein cleavage: interaction of zinc with capsid polypeptides. J. Virol. 18(1), 298–306 (1976).
- Marone G, Columbo A, De Paulis A, Cirillo R, Giugliano R, Condorelli M. Physiological concentrations of zinc inhibit the release of histamine from human basophils and lung mast cells. Agents Actions 18(5), 607 (1986).
- Petrus EJ, Lawson KA, Bucci LR, Blum K. Randomized, double-masked, placebo controlled, clinical study of the effectiveness of zinc acetate lozenges on common cold symptoms in allergy-tested subjects. Curr. Ther. Res. 59(9), 595–607 (1998).
- Eby GA 3rd. Zinc lozenges as cure for the common cold – a review and hypothesis. Med. Hypotheses 74(3), 482–492 (2010).